Agrenvec
PrivateLast Round
Grant
Feb 26, 2025
Total Funding Raised
$1.26M
Company Overview
Agrenvec is a biotechnology company that specializes in the plant-based manufacturing of high-quality recombinant human proteins for skincare, diagnostics, research, and biotechnological applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clean Manufacturing, Fashion & Beauty, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Agrenvec Comparables
Compare Agrenvec with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Leaf Expression Systems | 88% | |
| ORF Genetics | 88% | |
| Cape Bio Pharms | 86% |
Agrenvec Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 26, 2025 | ||||
| Grant | Dec 30, 2022 | ||||
| Series A | Apr 27, 2010 |
Agrenvec Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AXIS Participaciones Empresariales | Series A |
| European Union NextGenerationEU | Grant |
| Criteria Capital Risc | Series A |
| Center for Technological Development and Innovation | Grant |
Agrenvec Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Agrenvec's valuation, stock price, and market status.
Is Agrenvec a public or private company?
Agrenvec is a private company.
What is the current stock price of Agrenvec?
Agrenvec is a private company with no public stock price. No recent secondary market data is available.
How much is Agrenvec worth (valuation)?
Valuation information for Agrenvec is not publicly available.
Can I buy Agrenvec stock?
Agrenvec shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Agrenvec's last funding round?
Agrenvec's most recent funding round was Grant on February 26, 2025.
Who are the main investors in Agrenvec?
Key investors in Agrenvec include AXIS Participaciones Empresariales, European Union NextGenerationEU, Caixa Capital Risc, Center for Technological Development and Innovation.
Will Agrenvec IPO soon?
No public IPO plans have been announced for Agrenvec.
How can I track Agrenvec secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Agrenvec's secondary market activity and sign up for updates.